OSI-774

DRUG4 trials

Sponsors

The University of Texas Health Science Center at San Antonio, M.D. Anderson Cancer Center, Dana-Farber Cancer Institute, SCRI Development Innovations, LLC

Conditions

Head and Neck CancerKidney CancerNeoplasm MetastasisPancreatic Cancer

Phase 2

Erlotinib in Treating Patients With Advanced Kidney Cancer

CompletedNCT00045487

The University of Texas Health Science Center at San AntonioKidney Cancer

Start: 2002-06-30End: 2008-05-31Updated: 2014-01-27

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

CompletedNCT00076310

M.D. Anderson Cancer CenterHead and Neck Cancer

Start: 2004-01-28End: 2025-05-01Updated: 2026-07-22

Tarceva and Capecitabine for Pancreatic Cancer

CompletedNCT00125021

Dana-Farber Cancer InstituteNeoplasm Metastasis, Pancreatic Cancer

Start: 2003-10-31End: 2008-09-30Updated: 2009-11-02

OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma

CompletedNCT00193154

SCRI Development Innovations, LLCKidney Cancer

Start: 2003-02-28End: 2014-03-31Updated: 2014-04-01